New Study Evaluates High Dose Ivermectin, Fluvoxamine, and Metformin for Outpatient COVID-19 [rYejoI5hcYU]

New Study Evaluates High Dose Ivermectin, Fluvoxamine, and Metformin for Outpatient COVID-19 [rYejoI5hcYU]

| 1h 28m 28s | Video has closed captioning.

Roger Seheult, MD of MedCram examines a new study comparing high dose Ivermectin, Fluvoxamine, and Metformin for outpatient COVID-19. See all Dr. Seheult's videos at: (This video was recorded on August 26, 2022) Roger Seheult, MD is the co-founder and lead professor at He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. LINKS / REFERENCES: Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 (NEJM) | Mission (Parsemus Foundation) | Prevention Protocol (FLCCC) | All coronavirus updates are at MedCram.com (including more discussion on delta variant covid, COVID Delta, COVID children, natural immunity COVID 19, and more). MedCram Update 46: MedCram Update 47: MedCram Update 132: SUBSCRIBE TO THE MEDCRAM YOUTUBE CHANNEL: Get notified of new videos by hitting the bell icon MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at [email protected] if you are interested. MEDIA CONTACT: Media Contact: [email protected] Media contact info: Video Produced by Kyle Allred FOLLOW US ON SOCIAL MEDIA: DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor. #COVID19 #Omicron #Coronavirus #simply lean keto acv #bad effects of diet pills #action weight loss pills #v2 keto gummies